Frec Markets’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.44M Buy
24,003
+3,448
+17% +$217K 0.09% 242
2026
Q2
$1.18M Buy
20,555
+15,823
+334% +$867K 0.11% 193
2026
Q1
$267K Buy
+4,732
New +$276K 0.05% 475

Other funds holding BMRN

Frec Markets's BMRN Position: Q3 2026 in Review

Frec Markets increased its BioMarin Pharmaceuticals (BMRN) stake by 17% in Q3 2026, buying an estimated $217K and bringing the position to 24,003 shares worth $1.44M. The position accounts for 0.09% of the portfolio, ranked #242.

Frec Markets first reported a position in BMRN in Q1 2026 and has held it in 3 quarters since. 567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • Frec Markets held 24,003 shares of BioMarin Pharmaceuticals worth $1.44M as of Q3 2026.
  • Frec Markets bought 3,448 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $217K.
  • BioMarin Pharmaceuticals made up 0.09% of Frec Markets's portfolio in Q3 2026, its #242 holding.
  • Frec Markets first reported a position in BioMarin Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Frec Markets's 13F filing for Q3 2026, filed 16 Nov 2026.